Literature DB >> 8878496

Changing causes of mortality in patients with familial adenomatous polyposis.

L A Belchetz1, T Berk, B V Bapat, Z Cohen, S Gallinger.   

Abstract

Widespread use of prophylactic colectomy has resulted in a reduction in the incidence of colorectal cancer in familial adenomatous polyposis (FAP) patients. A retrospective chart review of families registered at the Steve Atanas Stavro Familial Gastrointestinal Cancer Registry in Toronto was performed to determine whether the decrease in the number of patients developing colorectal cancer implies that causes of mortality in FAP patients are shifting to that of extracolonic manifestations of FAP. Information was available on 140 deaths within 158 families and among 461 individuals with FAP. When stratified by decade, from the 1930s to the 1990s, the ratio of deaths caused by extracolonic manifestations of FAP compared with deaths caused by colorectal cancer was noted to have risen. Even though most deaths in FAP patients are still from colorectal cancer, it appears that screening policies and prophylactic colectomy have resulted in a reduction in the number of FAP patients who develop colorectal cancer. Thus, in recent decades, a greater percentage of deaths in FAP patients appears to be attributable to extracolonic manifestations of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8878496     DOI: 10.1007/bf02054051

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  44 in total

1.  FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.

Authors:  Henry T Lynch; Carrie Snyder; Janine M Davies; Stephen Lanspa; Jane Lynch; Zoran Gatalica; Victoria Graeve; Jason Foster
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Villous tumors of the duodenum: reappraisal of local vs. extended resection.

Authors:  M B Farnell; G H Sakorafas; M G Sarr; C M Rowland; G G Tsiotos; D R Farley; D M Nagorney
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

3.  Inherited colorectal cancer syndromes.

Authors:  Robert Gryfe
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 4.  [Preventive surgery for familial adenomatous polyposis coli].

Authors:  M Kadmon
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

5.  Psychosocial impact of familial adenomatous polyposis on young adults: a qualitative study.

Authors:  Shab Mireskandari; Jennifer Sangster; Bettina Meiser; Belinda Thewes; Claire Groombridge; Allan Spigelman; Lesley Andrews
Journal:  J Genet Couns       Date:  2009-05-29       Impact factor: 2.537

6.  A useful reconstruction arrangement following Whipple's resection for patients with familial adenomatous polyposis.

Authors:  Siong-Seng Liau; Asif Jah; Emmanuel Huguet; Neville Jamieson; Raaj Praseedom
Journal:  Ann R Coll Surg Engl       Date:  2009-10       Impact factor: 1.891

7.  Feasibility of endoscopic resection using bipolar snare for nonampullary duodenal tumours in familial adenomatous polyposis patients.

Authors:  Kazuya Inoki; Takeshi Nakajima; Satoru Nonaka; Seiichiro Abe; Haruhisa Suzuki; Shigetaka Yoshinaga; Ichiro Oda; Masayoshi Yamada; Mizuki Takatsu; Hiroshi Yoshida; Hirokazu Taniguchi; Shigeki Sekine; Yuichiro Ohe; Yutaka Saito
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

8.  Evaluating causes of death in familial adenomatous polyposis.

Authors:  Fábio Guilherme C M de Campos; Rodrigo Oliva Perez; Antônio Rocco Imperiale; Víctor Edmond Seid; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

Review 9.  Clinical management of hereditary colorectal cancer syndromes.

Authors:  Hans F A Vasen; Ian Tomlinson; Antoni Castells
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 46.802

10.  Laparoscopic colectomy for cancer.

Authors:  David W Larson; Heidi Nelson
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.